Hapvida is one of Brazil’s largest private health-plan operators, built on an unusual idea: own the hospitals and clinics, not just the insurance. That vertical model delivered years of spectacular profits – but a difficult post-merger integration has turned the last three years into a test of resilience. Full nameHapvida Participações e Investimentos S.A. Tickers / exchangeHAPV3 / B3 (São Paulo) HeadquartersFortaleza, Ceará, Brazil SectorHealthcare – health and dental plans, own hospital/clinic network EmployeesNot disclosed in available sources Market valueR$ 5.41 billion (US$ 1.06 billion) Yearly sales (TTM)R$ 31.85 billion (US$ 6.26 billion) Net profit (TTM)–R$ 141.7 million (US$ –27.8 million) – …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Latest coverage
Brazil Blocks Health Insurer Hapvida From Repricing 947,000 Plans
Hapvida’s Adjusted Q2 Profit All but Vanishes as Medical Costs Climb
Brazil’s Hapvida to Launch Premium NotreDame Health Plan
Hapvida Profit Plunges 65% as Claims Rise and Members Leave
Ibovespa Slips As Wall Street Selloff And Hapvida Rout Break Winning Streak
Read More from The Rio Times